公开(公告)号：US06491672B2

公开(公告)日：2002-12-10

申请号：US09778651

申请日：2001-02-07

Applicant: Marvin J. Slepian ,  Daniel Yachia ,  Syed Hossainy ,  Baruch Levy ,  Zeev Sohn

Inventor： Marvin J. Slepian ,  Daniel Yachia ,  Syed Hossainy ,  Baruch Levy ,  Zeev Sohn

IPC: A61M2500

CPC classification number: A61B17/320758 ,  A61B17/00491 ,  A61B17/320725 ,  A61B90/361 ,  A61B2017/00274 ,  A61B2017/00557 ,  A61B2017/22072 ,  A61B2017/3445 ,  A61B2018/00547

Abstract: A process has been developed to reduce or relieve prostatic obstruction. The steps involved in the TUVOR Process include: 1. Transurethral Incision; 2. De-bulking and Intra-Prostatic Volume Reduction; 3. Intra-prostatic void exclusion and space filling with adhesive and/or therapeutic polymeric materials, alone or in combination with bioactive agents and/or mechanical means for closure; 4. Endourethral compression and prostatic mass remolding; 5. Endourethral Polymer Liner Layer. This liner formed from structurally supportive, yet eventually biodegradable, polymers further bolsters and supports the urethra and peri-urethral tissue during healing, eliminating the need for post-procedure catheter drainage. This step may be optional in specific clinical circumstances. The process is designed to allow outpatient treatment under local anesthesia for BPH.

Abstract translation: 已经开发了一种减轻或缓解前列腺阻塞的过程。 TUVOR过程涉及的步骤包括：1.经尿道切口; 减少体重和体内前列腺减少; 3.用粘合剂和/或治疗性聚合物材料单独或与生物活性剂和/或用于封闭的机械装置组合的前列腺空洞排除和空间填充; 4.尿道压迫和前列腺体重重塑; 5.尿道内聚合物衬里层。 由结构支持但最终可生物降解的聚合物形成的衬垫在愈合过程中进一步支撑和支撑尿道和尿道周围组织，从而无需进行后路导管引流。 在特定临床情况下，此步骤可能是可选的。 该过程设计为允许门诊在局部麻醉下进行BPH治疗。